Skip to Main Content

Author Details

Michael Denton
Vaccine and Gene Therapy Institute, Oregon Health and Science University
2001
21
11
PMIDPaper TitleJournal TitlePublished Year
36913428Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoprotein.PLoS Negl Trop Dis2023
37782657Proximity-dependent mapping of the HCMV US28 interactome identifies RhoGEF signaling as a requirement for efficient viral reactivation.PLoS Pathog2023
37983245Mayaro virus pathogenesis and immunity in rhesus macaques.PLoS Negl Trop Dis2023
34152810Identification of Quinolinones as Antivirals against Venezuelan Equine Encephalitis Virus.Antimicrob Agents Chemother2021
33601113Rat and human cytomegalovirus ORF116 encodes a virion envelope glycoprotein required for infectivity.Virology2021
33793555Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.PLoS Negl Trop Dis2021
33228102Rat Cytomegalovirus Virion-Associated Proteins R131 and R129 Are Necessary for Infection of Macrophages and Dendritic Cells.Pathogens2020
31736977Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease.Front Immunol2019
29343712Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology.Nat Commun2018
28628616Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques.PLoS Negl Trop Dis2017
28278237Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues.PLoS Pathog2017
28380070Correction: Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues.PLoS Pathog2017
25766876Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV-Naïve Recipients of Infected Donor Allograft Hearts.Am J Transplant2015
24829346Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.J Virol2014
22915808Cytomegalovirus CC chemokine promotes immune cell migration.J Virol2012
20848030Polymeric PARACEST MRI contrast agents as potential reporters for gene therapy.Org Biomol Chem2010
19403663Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.J Virol2009
16731524The role of BiP in endoplasmic reticulum-associated degradation of major histocompatibility complex class I heavy chain induced by cytomegalovirus proteins.J Biol Chem2006
15196940Receptor binding specificities of Herstatin and its intron 8-encoded domain.FEBS Lett2004
14603258Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2.Oncogene2003
11526509Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor.Oncogene2001
  • 1 - 21 of 21

Recommended Authors

Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 1
David Geffen School of Medicine, University of California los angeles
Career Start Year 2009
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 0
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 0
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 1
Institute of Tropical Medicine
Career Start Year 2007
Number of shared co-authors 0
Ottawa Hospital Research Institute
Career Start Year 2006
Number of shared co-authors 0
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 4
Minnesota Supercomputing Institute, University of Minnesota
Career Start Year 2003
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 5
University of Toledo
Career Start Year 2002
Number of shared co-authors 0
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1997
Number of shared co-authors 2
Profectus BioSciences Inc.
Career Start Year 1997
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 6
Center for Global Infectious Disease Research, Seattle Children's Hospital
Career Start Year 1997
Number of shared co-authors 0
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1996
Number of shared co-authors 4
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 7
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 4
University of California Berkeley
Career Start Year 1993
Number of shared co-authors 1
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 0
University of California los angeles
Career Start Year 1992
Number of shared co-authors 0
Merck & Co., Inc.
Career Start Year 1989
Number of shared co-authors 0
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 3
Wistar Institute
Career Start Year 1986
Number of shared co-authors 2
Ben-Gurion University of the Negev
Career Start Year 1984
Number of shared co-authors 1
University of Texas Medical Branch
Career Start Year 1983
Number of shared co-authors 0
University of North Carolina
Career Start Year 1981
Number of shared co-authors 5
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 2
University of North Carolina at Chapel Hill
Career Start Year 1973
Number of shared co-authors 3

Collaborators

Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 16
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 13
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 7
University of Colorado Anschutz Medical Campus
Co-authored papers 4
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 3
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 3
Oregon Health and Science University
Co-authored papers 3
University of North Carolina at Chapel Hill.
Co-authored papers 3
Washington University School of Medicine
Co-authored papers 2
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 1
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 1
University of Texas Medical Branch
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 1
Louisiana State University
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 1
Oregon Health and Science University
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Oregon Health and Science University
Co-authored papers 1